Heterozygous FV R506Q mutation in childhood thrombosis: A possible link to the plasminogen activator inhibitor-1 (PAI-1) 4G/4G genotype and elevated lipoprotein (a) preliminary results of a single centre pilot study

Fibrinolysis and Proteolysis

Volumn 13, Issue SUPPL. 1, 1999, Pages 26-29

  Junker, R ^a,b   Baumer R ^a   Koch, H G ^a   Schettler, Ch ^b   Weber, D ^b   Nowak Gottl U ^b  

^a Inst for Arteriosclerosis Research   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; LIPOPROTEIN A; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN C; PROTEIN S;

ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; GENOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MUTATION; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DEFICIENCY; RISK FACTOR; THROMBOSIS;

EID: 0033001259     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76:65 1-2
2. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 2. Thromb Haemost 1996; 76: 823-34
3. Engesser L, Brommer EJP, Kluft C, Briet E. Elevated plasminogen activator inhibitor (PAI), a cause of thrombophilia? A study in 203 patients with familial or sporadic thrombophilia. Thromb Haemost 1989; 62: 673-80
4. Heijboer H, Brandjes DPM, Büller HR, Sturk A, ten Cate LW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep vein thrombosis. N Engl J Med 1990; 323: 1512-6
5. Pabinger I, Bruckner S, Kyrie PA, Schneider B. Korninger HC, Niessner H, Lechner K. Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coagul Fibrinol 1992; 3: 547-53
6. Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J, and the EMET group. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism - results of the Spanish multicentric study on thrombophilia (EMET-Study). Thromb Haemost 1997; 77: 444-51
7. Seligsohn U, Zivelin A. Thrombophilia as a multigenetic disorder. Thromb Haemost 1997; 78( 1 ): 297-01
8. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504-8
9. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Audria G, Boers GHJ, Homberg IL, Cerone R, Fowler B, Grobe H, Schmidt H, Schweitzer L. The natural history of homocystinuria due to cystathionine-synthase deficiency. Am J Hum Genet 1985; 37: 1-31
10. Jürgens G, Költringer P. Lipoprotein (a) in ischémie cerebrovascular disease: A new approach to the assessment of risk for stroke. Neurology 1987; 37: 513-5
11. Nowak-Göttl U, Debus O, Findeisen M, Kassenböhmer R, Koch HG, Pollmann H, Postler C, Weber P, Vielhaber H. Lipoprotein (a): its role in childhood thromboembolism. Pediatrics (electronic pages) 1997; 99/6el 1
12. Wiman B. Plasminogen activator inhibitor-1 (PA1-1) in plasma: its role in thrombotic disease. Thromb Haemost 1995; 74: 71-6
13. Juan-Vague I, Valadier J, Alessi MC, Aillaud MF, Ansaldi J, Philip Joet C, Holovoet P, Serradimigni A, Collen D. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemost 1987; 57: 67-72
14. Nowak-Gottl U, Vielhaber H, Grohmann J, Schneppenheim R, Koch HG. Arg 506 to Gin mutation in the factor V gene in infancy and childhood: evidence of fibrinolytic impairment. Eur J Pediatr 1997; 156: 195-8
15. Nowak-Göttl U, Binder M. Dübbers A, Kehrel B, Koch HG. Veitmann H, Vielhaber H. Arg to Gin mutation in the factor V gene causes poor fibrinolytic response in children after venous occlusion. Thromb Haemost 1997; 78: 1115-8
16. Bajzar L, Kalafatis M. Simioni P, Tracy PB. An antifibrinolytic mechanism describing the prothrombotic effect associated with factor V Leiden. J Biol Chem 1996; 271: 22949-052
17. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S. Henney AM. The two allele sequences of a common polymorphism in the promotor of the plasminogen activator inhibitor-! (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993; 268: 10739-45
18. Nowak-Göttl U, Koch HG, Aschka I, Kohlhase B, Vielhaber H, Kuriemann G. Oleszuk-Raschke K, Kehl HG, Jürgens H, Schneppenheim R. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Brit J Haematol 1996; 92, 992-6
19. Falk G. Almqvist A, Nordenhem A, Svensson H, Wiman B. Allele specific PCR for detection of a sequence polymorphism in the promotor region of the plasminogen activator inhibitor-1 (PAI-1) gene. Fibrinolysis 1995; 9: 170-4
20. Bertina RM, Koelemann BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7
21. Boven van HH. Reitsma PH. Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA. Scharrer 1, Conard J, Lane DA. Factor V Leiden (FVR506Q) in families with inherited antithrombin deficiency. Thromb Haemost 1996; 75: 417-21
22. Eriksson P, Kallin B, Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sei USA 1995: 92: 185 1 -5
23. Ossei-Gerning N, Mansfield MW, Stickland MH, Wilson 1J, Grant PJ. Plasminogen activator inhibitor-1 promotor 4G/4G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography. Arterioscler Thromb Vase Biol 1997; 17: 33-37
24. Zöller B. Garcia de Frutos P, Dahlbäck B. A common 4G allele in the promotor of the plasminogen activator inhibitor -1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency. Thromb Haemost 1998; 79: 802-807
25. Koeleman BPC Reitsma PH. Bakker E. Bertina RM. Location on the human genetic linkage map of 26 genes involved in blood coagulation. Thromb Haemost 1997; 77: 873-878